http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-505212-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cee5f6b519deb93e9abc825a891a5e5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 |
| filingDate | 2000-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bc5484d77573412667b3ab03564f38d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d66e13a21c2caea1a04d149d48c41a |
| publicationDate | 2003-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-505212-A |
| titleOfInvention | Benzoxazine compounds useful for enhancing synaptic response |
| abstract | A benzoxazine derivative has the formula (I) wherein: X1 and X1 are independently H, N(R3)2, OR4 or CH2OR4 or together are O(CR5)2O, O(CR5)2(CR5)2O, OCR5= CR5, N=CR6CR6=N, N=CR3NR3, =N-O-N=, =N-S-N= or OCR3=N-; Z is O, NR7 or S; each R1 is independently H, alkyl, or fluoroalkyl, each R2 is independently H, halogen, cyano, hydroxy, alkoxy, fluoroalkoxy, thiol, alkyl, fluoroalkyl, alkoxyalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, aryloxy, aryloxyalkyl, arylalkoxy, or heteroarylalkoxy; each R3 and R7 is independently H, alkyl, fluoroalkyl, arylalkyl or heteroarylalkyl; each R4 is independently H, alkyl, fluoroalkyl, alkoxyalkyl, arylalkyl, heteroarylalkyl or aryloxyalkyl; each R5 is H, halogen, cyano, alkyl, fluoroalkyl, alkoxyalkyl, arylalkyl, heteroarylalkyl or aryloxyalkyl; each R6 is H, cyano, hydroxy, alkoxy, alkyl, fluoroalkyl, alkoxyalkyl, arylalkyl, heteroarylalkyl, aryloxy, aryloxyalkyl, arylalkoxy, or heteroarylalkoxy; and n is 2, 3 or 4. A pharmaceutical composition thereof is useful for treating schizophrenia, schizophrenia behaviour or depression. |
| priorityDate | 1997-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808 |
Total number of triples: 28.